-
Endpoints News2 weeks ago
Limbic aims to show AI beats humans in delivering therapy
A March study in Nature Medicine showed that AI designed for therapy can deliver better care than human clinicians in a specific type of therapy. UK-based...
-
AI & Machine Learning in Biotechnology2 weeks agoWhite House misses deadline to nominate new CDC director
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. So you know how Theresa said yesterday that...
-
Endpoints News2 weeks ago
Post-Hoc: It’s time to make ACIP serious again
Who knows what’s going to happen to the Advisory Committee on Immunization Practices? Former member Robert Malone suggested in a string of social media posts last...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: Data show people racing to chatbots for health advice
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
GEN – Genetic Engineering & Biotechnology News2 weeks agoFrom Variability to Reliability: A New IgG4 Reference Standard for Consistent Characterization
Register Now Panelists: Derrick Zhang Senior Scientist IIUS Pharmacopeia (USP) View Bio Panelist Derrick Zhang Derrick Zhang is a senior scientist II at the US Pharmacopeia...
-
STAT News – Biotech2 weeks agoSTAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Top of the morning to you, and a fine one it is. Sunny skies and mild breezes are enveloping the Pharmalot campus once again. And to...
-
Fierce Biotech2 weeks ago
CMR Surgical kicks off Versius Plus robot’s US commercial launch
Following FDA approval last December for its upgraded robot, CMR Surgical has begun rolling out its Versius Plus platform in the U.S.
-
Uncategorized2 weeks ago
Beam’s Base Editor Advances to Pivotal Development on Back of ‘Impressive’ AATD Data
Beam is now in the strongest position of all companies advancing a genetic therapy for alpha-1 antitrypsin deficiency, according to analysts at William Blair.
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Georgia Chosen as the Location for UCB’s New U.S. Biologics Manufacturing Facility
Belgium-based UCB selected Gwinnett County, Georgia, as the location for its new U.S. biologics manufacturing facility. The campus will use a digital-first approach by leveraging AI,...
-
Uncategorized2 weeks ago
Denali Delivers ‘Welcome Positive’ for Rare Disease Space With FDA’s Hunter Syndrome Nod
Avlayah is the first Hunter syndrome therapy approved to address the condition’s neurologic complications, according to Tracy Beth Høeg, acting director of the Center for Drug...
High-Throughput Platform for Fast-Acting Covalent Protein Therapies
Terns rebuffed a higher bid before selling to Merck
